CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling.

B cell-specific gene ablation of Notch2 results in the loss of the marginal zone (MZ) B-cell lineage. To analyze the effects of constitutive Notch2 signaling in B cells, we have generated a transgenic mouse strain that allows the conditional expression of a constitutively active, intracellular form of Notch2 (Notch2IC). Expression of Notch2IC at the earliest developmental stages of the B-cell lineage completely abolished B-cell generation and led to the development of ectopic T cells in the bone marrow (BM), showing that Notch2IC is acting redundantly with Notch1IC in driving ectopic T-cell differentiation. In B cells clearly committed to the B-cell lineage induction of Notch2IC drove all cells toward the MZ B-cell compartment at the expense of follicular B cells. Notch2IC-expressing B cells reflected the phenotype of wild-type MZ B cells for their localization in the MZ, the expression of characteristic surface markers, their enhanced proliferation after stimulation, and increased basal activity of Akt, Erk, and Jnk. Notch2IC-driven MZ B-cell generation in the spleen was achieved even in the absence of CD19. Our results implicate that a constitutive Notch2 signal in transitional type 1 B cells is sufficient to drive MZ B-cell differentiation.

[1]  M. Birnbaum,et al.  Akt1 and Akt2 promote peripheral B-cell maturation and survival. , 2010, Blood.

[2]  J. Weis,et al.  The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors , 2010, European journal of immunology.

[3]  H. Macdonald,et al.  Notch signaling in the immune system. , 2010, Immunity.

[4]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.

[5]  U. Weidle,et al.  Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells. , 2009, Blood.

[6]  A. Bandaranayake,et al.  Reduced c-myc Expression Levels Limit Follicular Mature B Cell Cycling in Response to TLR Signals1 , 2009, The Journal of Immunology.

[7]  S. Egan,et al.  Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. , 2009, Immunity.

[8]  K. Ando,et al.  Expression of Delta-like 1 in the splenic non-hematopoietic cells is essential for marginal zone B cell development. , 2008, Immunology letters.

[9]  K. Rajewsky,et al.  Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis , 2008, The Journal of experimental medicine.

[10]  K. Okumura,et al.  Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice. , 2008, International immunology.

[11]  K. Rajewsky,et al.  LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. , 2008, Blood.

[12]  C. Boboila,et al.  The Recirculating B Cell Pool Contains Two Functionally Distinct, Long-Lived, Posttransitional, Follicular B Cell Populations1 , 2007, The Journal of Immunology.

[13]  W. Wurst,et al.  Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference , 2007, Nucleic acids research.

[14]  W. Pear,et al.  Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. , 2007, Blood.

[15]  Wei Li,et al.  Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis. , 2007, Molecular immunology.

[16]  M. Reth,et al.  Testing gene function early in the B cell lineage in mb1-cre mice , 2006, Proceedings of the National Academy of Sciences.

[17]  David Allman,et al.  Regulation of peripheral B cell maturation. , 2006, Cellular immunology.

[18]  D. Allman,et al.  Characterization of marginal zone B cell precursors , 2005, The Journal of experimental medicine.

[19]  T. Phan,et al.  Altered Migration, Recruitment, and Somatic Hypermutation in the Early Response of Marginal Zone B Cells to T Cell-Dependent Antigen1 , 2005, The Journal of Immunology.

[20]  N. Tamaoki,et al.  Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo , 2004, Nature Immunology.

[21]  C. S. Swindle,et al.  Activated Notch2 Potentiates CD8 Lineage Maturation and Promotes the Selective Development of B1 B Cells , 2003, Molecular and Cellular Biology.

[22]  S. Aizawa,et al.  Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. , 2003, Immunity.

[23]  J. Kearney,et al.  Marginal-zone B cells , 2002, Nature Reviews Immunology.

[24]  T. Honjo,et al.  Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells , 2002, Nature Immunology.

[25]  S. Shinton,et al.  Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation1 , 2001, The Journal of Immunology.

[26]  L. Strobl,et al.  EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. , 2001, Seminars in cancer biology.

[27]  R. Hardy,et al.  B cell development pathways. , 2001, Annual review of immunology.

[28]  J. Kearney,et al.  B1 cells: similarities and differences with other B cell subsets. , 2001, Current opinion in immunology.

[29]  L. Strobl,et al.  Activated Notch1 Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMP1-Expressing Immortalized B Cells , 2001, Journal of Virology.

[30]  Y. Kanda,et al.  Binding of Delta1, Jagged1, and Jagged2 to Notch2 Rapidly Induces Cleavage, Nuclear Translocation, and Hyperphosphorylation of Notch2 , 2000, Molecular and Cellular Biology.

[31]  J. Aster,et al.  Notch1 expression in early lymphopoiesis influences B versus T lineage determination. , 1999, Immunity.

[32]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[33]  J. Kearney,et al.  IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. , 1999, Journal of immunology.

[34]  P. Cohen,et al.  Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B* , 1999, The Journal of Biological Chemistry.

[35]  Geert J. P. L. Kops,et al.  Direct control of the Forkhead transcription factor AFX by protein kinase B , 1999, Nature.

[36]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[37]  K. Rajewsky,et al.  B lymphocyte-specific, Cre-mediated mutagenesis in mice. , 1997, Nucleic acids research.

[38]  Klaus Rajewsky,et al.  Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.

[39]  B. Koller,et al.  Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.

[40]  D. Tuveson,et al.  The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. , 1991, Journal of immunology.

[41]  B. Dörken,et al.  CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. , 1987, Journal of immunology.